Cross-cultural validation and measurement invariance of anxiety and depression symptoms: A study of the Brief Symptom Inventory (BSI) in 42 countries
Impacto
![Google Scholar](/xmlui/themes/Mirage2/images/uji/logo_google.png)
![Microsoft Academico](/xmlui/themes/Mirage2/images/uji/logo_microsoft.png)
Metadatos
Mostrar el registro completo del ítemcomunitat-uji-handle:10234/9
comunitat-uji-handle2:10234/8033
comunitat-uji-handle3:10234/8636
comunitat-uji-handle4:
INVESTIGACIONEste recurso está restringido
https://doi.org/10.1016/j.jad.2024.01.127 |
Metadatos
Título
Cross-cultural validation and measurement invariance of anxiety and depression symptoms: A study of the Brief Symptom Inventory (BSI) in 42 countriesAutoría
Fecha de publicación
2024-02-01Editor
ElsevierISSN
0165-0327; 1573-2517Cita bibliográfica
Quintana, G. R., Ponce, F. P., Escudero-Pastén, J. I., Santibáñez-Palma, J. F., Nagy, L., Koós, M., ... & Bőthe, B. (2024). Cross-cultural validation and measurement invariance of anxiety and depression symptoms: A study of the Brief Symptom Inventory (BSI) in 42 countries. Journal of affective disorders, 350, 991-1006.Tipo de documento
info:eu-repo/semantics/articleVersión
info:eu-repo/semantics/publishedVersionPalabras clave / Materias
Resumen
Background
Depression and anxiety are among the most prevalent mental health issues experienced worldwide. However, whereas cross-cultural studies utilize psychometrically valid and reliable scales, fewer can meani ... [+]
Background
Depression and anxiety are among the most prevalent mental health issues experienced worldwide. However, whereas cross-cultural studies utilize psychometrically valid and reliable scales, fewer can meaningfully compare these conditions across different groups. To address this gap, the current study aimed to psychometrically assess the Brief Symptomatology Index (BSI) in 42 countries.
Methods
Using data from the International Sex Survey (N = 82,243; Mage = 32.39; SDage = 12.52; women: n = 46,874; 57 %), we examined the reliability of depression and anxiety symptom scores of the BSI-18, as well as evaluated evidence of construct, invariance, and criterion-related validity in predicting clinically relevant variables across countries, languages, genders, and sexual orientations.
Results
Results corroborated an invariant, two-factor structure across all groups tested, exhibiting excellent reliability estimates for both subscales. The ‘caseness’ criterion effectively discriminated among those at low and high risk of depression and anxiety, yielding differential effects on the clinical criteria examined.
Limitations
The predictive validation was not made against a clinical diagnosis, and the full BSI-18 scale was not examined (excluding the somatization sub-dimension), limiting the validation scope of the BSI-18. Finally, the study was conducted online, mainly by advertisements through social media, ultimately skewing our sample towards women, younger, and highly educated populations.
Conclusions
The results support that the BSI-12 is a valid and reliable assessment tool for assessing depression and anxiety symptoms across countries, languages, genders, and sexual orientations. Further, its caseness criterion can discriminate well between participants at high and low risk of depression and anxiety. [-]
Publicado en
Journal of Affective Disorders 350 (2024) 991–1006Datos relacionados
https://ars.els-cdn.com/content/image/1-s2.0-S0165032724001447-mmc1.docxEntidad financiadora
WUN Research Development Fund (RDF) 2021 | Higher Education Sprout Project | Ministry of Education at the Headquarters of University Advancement at the National Cheng Kung University (NCKU) | Chaire Professeur Junior of Artois University and by the Strategic Dialogue and Management Scholarship | Japan Society for The Promotion of Science | Smoking Research Foundation | Kindbridge Research Institute | Charles University institutional support programme Cooperatio-Health Sciences | National Science Centre, Poland | Hauts-de-France Regional Council (France) | National Social Science Foundation of China | New National Excellence Program of the Ministry for Culture and Innovation from the source of the National Research, Development and Innovation Fund.; MG was supported by National Science Centre, Poland | Hungarian National Research, Development, and Innovation Office
Código del proyecto o subvención
SNI #073–2022 | JP21H05173 | 21H02849 | 23K07013 | 2020/36/C/HS6/00005 | DSG2 | Grant No. 19BSH117 | ÚNKP-22-3 | 2021/40/Q/HS6/00219 | ÚNKP-22-3 | KKP126835
Derechos de acceso
0165-0327/© 2024 Elsevier B.V. All rights reserved.
http://rightsstatements.org/vocab/InC/1.0/
info:eu-repo/semantics/restrictedAccess
http://rightsstatements.org/vocab/InC/1.0/
info:eu-repo/semantics/restrictedAccess
Aparece en las colecciones
- PSB_Articles [1315]